Weekly Recap | Novavax -11.69%, biotech rally takes a breatherWeekly Review·Oct 17, 2026 at 07:48 AMNVAX-12.17%
Weekly Recap | Novavax +21.89%, flows turn net sellerWeekly Review·Oct 10, 2026 at 07:20 AMNVAX-12.17%
Weekly Recap | Novavax -1.6%, consensus target a third aboveWeekly Review·Oct 3, 2026 at 07:22 AMNVAX-12.17%
Weekly Recap | Novavax +5.14%, consensus target above spotWeekly Review·Sep 26, 2026 at 06:55 AMNVAX-12.17%
Weekly Recap | Novavax +7.32%, outperforming the S&P 500Weekly Review·Sep 19, 2026 at 06:28 AMNVAX-12.17%
Weekly Recap | Novavax +10.37%, consensus target above spotWeekly Review·Sep 5, 2026 at 07:33 AMNVAX-12.17%
Weekly Recap | Novavax +3.58%, consensus target above spotWeekly Review·Aug 29, 2026 at 06:08 AMNVAX-12.17%
